How are Pharmakogenetik Medicheck and blood sugar related?

The Pharmakogenetik Medicheck analyzes genetic variants affecting drug metabolism. A direct link to blood sugar exists primarily when medications that influence glucose metabolism are taken – e.g., statins, beta-blockers, antipsychotics, or certain antidiabetics. Genetic profiles (e.g., in CYP2C9, SLCO1B1, TCF7L2) can indicate risks for blood sugar elevations or altered efficacy of diabetes drugs. However, the test itself does not measure blood sugar; it provides clues about potential drug reactions. Evidence for such associations ranges from human-strong (e.g., metformin and SLC22A1/OCT1) to mechanistic. As a consumer test, it does not replace medical diagnosis. Elevated fasting glucose or HbA1c should always be evaluated clinically.